AstraZeneca Pharma India Limited (BOM:506820)
India
· Delayed Price · Currency is INR 6,976.50
+33.80 (0.49%)
At close: Feb 20, 2025
AstraZeneca Pharma India Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 19, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 171,719 | 133,010 | 81,183 | 63,886 | 75,255 | 59,789 | Upgrade
|
| Market Cap Growth | 32.43% | 63.84% | 27.07% | -15.11% | 25.87% | 19.68% | Upgrade
|
| Enterprise Value | 166,922 | 127,861 | 76,552 | 60,484 | 72,857 | 57,477 | Upgrade
|
| Last Close Price | 6868.75 | 5302.47 | 3222.61 | 2529.13 | 2977.28 | 2363.99 | Upgrade
|
| PE Ratio | 177.11 | 82.35 | 81.76 | 103.71 | 80.66 | 82.80 | Upgrade
|
| PS Ratio | 10.61 | 10.27 | 8.09 | 7.93 | 9.25 | 7.19 | Upgrade
|
| PB Ratio | 25.28 | 18.68 | 13.79 | 12.49 | 16.50 | 16.41 | Upgrade
|
| P/TBV Ratio | 26.98 | 18.74 | 13.79 | 12.49 | 16.50 | 16.41 | Upgrade
|
| P/FCF Ratio | - | 777.38 | 163.12 | 70.07 | 77.53 | 81.68 | Upgrade
|
| P/OCF Ratio | - | 477.25 | 139.27 | 63.38 | 71.82 | 68.39 | Upgrade
|
| EV/Sales Ratio | 10.31 | 9.87 | 7.63 | 7.51 | 8.96 | 6.91 | Upgrade
|
| EV/EBITDA Ratio | 80.60 | 69.81 | 47.45 | 73.16 | 54.94 | 48.72 | Upgrade
|
| EV/EBIT Ratio | 86.56 | 74.58 | 51.43 | 87.20 | 62.67 | 56.04 | Upgrade
|
| EV/FCF Ratio | - | 747.29 | 153.81 | 66.33 | 75.06 | 78.52 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.08 | 0.02 | 0.04 | 0.10 | 0.09 | 0.10 | Upgrade
|
| Debt / FCF Ratio | - | 0.27 | 0.14 | 0.09 | 0.13 | 0.16 | Upgrade
|
| Asset Turnover | - | 1.26 | 1.09 | 0.99 | 1.10 | 1.31 | Upgrade
|
| Inventory Turnover | - | 2.87 | 2.22 | 2.11 | 1.85 | 2.20 | Upgrade
|
| Quick Ratio | - | 1.89 | 1.61 | 1.64 | 1.46 | 1.06 | Upgrade
|
| Current Ratio | - | 2.61 | 2.18 | 2.12 | 2.04 | 1.66 | Upgrade
|
| Return on Equity (ROE) | - | 24.84% | 18.05% | 12.73% | 22.74% | 21.71% | Upgrade
|
| Return on Assets (ROA) | - | 10.39% | 10.10% | 5.31% | 9.81% | 10.11% | Upgrade
|
| Return on Capital (ROIC) | 17.77% | 16.33% | 16.67% | 8.77% | 17.21% | 18.93% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 23.78% | 24.77% | 13.24% | 24.67% | 27.05% | Upgrade
|
| Earnings Yield | 0.56% | 1.21% | 1.22% | 0.96% | 1.24% | 1.21% | Upgrade
|
| FCF Yield | 0.13% | 0.61% | 1.43% | 1.29% | 1.22% | Upgrade
| |
| Dividend Yield | 0.35% | 0.45% | 0.50% | 0.40% | 0.07% | 0.04% | Upgrade
|
| Payout Ratio | 0.00% | 24.77% | 20.14% | 8.12% | 5.36% | 3.46% | Upgrade
|
| Total Shareholder Return | 0.34% | 0.45% | 0.50% | 0.40% | 0.07% | 0.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.